We're proud to share that Magnif , a K-Beauty client of PCG, has officially launched at Sephora — one of the world's most selective beauty retailers. This is more than an expansion of distribution channels. It's proof that when exceptional product quality meets a solid regulatory foundation, even the biggest doors in global beauty can open. Who Is Brand Magnif ? Magnif is a clean beauty skincare brand that has built its reputation on ingredient transparency and genuine produ

Exosomes, PDRN, and post-procedure care. These are the hottest keywords in the global beauty market today. As K-Beauty shifts its focus from "Glass Skin" to "Recovery and Regeneration," the so-called K-Clinic  category is rapidly emerging. This is more than just a trend; consumers now expect professional, clinic-level results directly from their skincare products. However, the moment these expectations are translated into marketing copy, a significant risk arises in the U.S.

"Our product is a cosmetic — it just has an SPF rating." "Anti-dandruff shampoo is regulated as a drug?" If these questions sound familiar, your facility may already be at risk. You May Be Selling a Drug Without Knowing It The FDA classifies the following products not as cosmetics, but as OTC (over-the-counter) drugs : Sunscreens with SPF claims Acne products containing salicylic acid or benzoyl peroxide Anti-dandruff shampoos containing zinc pyrithione or selenium sulfide To

On March 5th, the FDA released a significant update that carries substantial weight for the industry. The agency has finalized a rule to unify the National Drug Code (NDC)—the identification number for all drugs sold in the U.S.—from the current 10-digit format to a standardized 12-digit format. Read More :   Final Rule "Revising the National Drug Code Format and Drug Label Barcode Requirements" Why FDA's NDC Matters Every product classified as a drug in the U.S. must have an

A fast-growing K-Beauty brand — call it Brand A — recently appeared in not one but two FDA public databases. First in CAERS, the FDA's cosmetics adverse event reporting system. Then in MAUDE, the medical device adverse event database. No recall. No import alert. But showing up across two separate FDA systems at the same time? That kind of thing gets noticed. Why an FDA Database Listing Is Never Just a Footnote CAERS and MAUDE are fully public. No login required. Any consumer,

The Shifting Landscape of K-Beauty: From ‘Topical’ to ‘Ingestible’ Global consumer research identifies the most significant shift in the recent beauty market as the expansion of beauty concepts—moving from "what you apply" to "what you consume." Consumers no longer see skincare as the exclusive domain of topical cosmetics; instead, they have begun to integrate dietary supplements and wellness products into their daily skincare routines. At the heart of this paradigm shift lie

The global popularity of K-Beauty is undisputed. However, establishing a "sustainable brand" in the U.S. market is an entirely different challenge. While the U.S. beauty market is massive, the barrier to entry is narrower and more complex than most realize. From product sourcing and manufacturing to quality control, logistics, and FDA compliance—handling these stages in silos has long burdened brands with excessive time, costs, and risks. To eliminate these trial-and-error se

The Next Frontier for K-Beauty: The Rise of "K-Beauty Devices" The global phenomenon of K-Beauty is no longer confined to skincare and cosmetics. By combining innovative ingredients and fast-paced trends with advanced technology, a new wave of "K-Beauty Devices" (or K-Devices) is rapidly gaining traction in the U.S. This category spans from at-home skin management devices and LED masks to MedSpa-inspired home-care tools that treat the face, scalp, and body simultaneously. U.S

Dear Valued Partners and Clients, As 2025 comes to a close, we look back on a year where the U.S. FDA regulatory landscape was more dynamic than ever—from the full-scale implementation of MoCRA to the restructuring of OTC regulations and the tightening of FSVP management. We would like to express our deepest gratitude to you for choosing Provision Consulting Group as your trusted partner during these rapidly changing times. Top 3 FDA Regulatory Updates of 2025 Here is a summa